Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Genmab (GMAB)

  • Event
  • June 27, 2022, 14:24 UTC
  • 19
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 27, 2022, 11:57 UTC
  • 19
  • 1 comments

(10% Negative) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 27, 2022, 11:44 UTC
  • 19
  • 1 comments

(85% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

BioNTech SE (BNTX)

  • Event
  • June 27, 2022, 11:25 UTC
  • 19
  • 1 comments

(80% Positive) BioNTech SE (BNTX) Announces Regulatory Update (Form 6-K)

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 27, 2022, 10:20 UTC
  • 19
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

BioNTech SE (BNTX)

  • Event
  • June 23, 2022, 20:34 UTC
  • 19
  • 1 comments

(90% Positive) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K)

Comment Full text

Genmab (GMAB)

  • Event
  • June 23, 2022, 16:02 UTC
  • 19
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

Galapagos NV (GLPG)

  • Event
  • June 23, 2022, 15:21 UTC
  • 19
  • 1 comments

(75% Positive) Galapagos NV (GLPG) Announces Clinical Development Update (Form 6-K)

Comment Full text

Galapagos NV (GLPG)

  • Event
  • June 23, 2022, 15:01 UTC
  • 19
  • 1 comments

(99% Neutral) Galapagos NV (GLPG) Files Form 6-K

Comment Full text

Affimed NV (AFMD)

  • Event
  • June 23, 2022, 11:28 UTC
  • 19
  • 1 comments

(99% Neutral) Affimed NV (AFMD) Announces 2022 Annual General Meeting

Comment Full text
  • Previous
  • 569
  • 570
  • 571
  • 572
  • 573
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284732)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162180)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin